Delivery Order SPE2DB20D3101-SPE2DB24FRTJ3

Award Date 8/28/24
Potential Completion Date 8/29/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,818.87 firm fixed-price delivery order is for the supply of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine. The contract has an ultimate completion date of March 24, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,071.03 firm fixed-price delivery order is for the supply of the TWINRIX vaccine, a hepatitis A and hepatitis B combination vaccine. The contract has an ultimate completion date of January 20, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite...
This contract award, valued at $26,997.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of TWINRIX vaccine syringes, a vaccine used to prevent hepatitis A and hepatitis B. This is a firm-fixed-price delivery order contract with an ultimate completion date of August 5, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a large Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,874.80 firm-fixed-price delivery order is for the supply of the TWINRIX vaccine, a hepatitis A and hepatitis B combination vaccine, and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $172,832.91 firm-fixed-price delivery order is for the TWINRIX vaccine, a combination hepatitis A and hepatitis B vaccine. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $13,656.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TWINRIX vaccine syringes, a vaccine for Hepatitis A and Hepatitis B. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an Ultimate Completion Date of August 28, 2024. It is not designated as a Set-Aside contract, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,122.32 firm fixed-price delivery order is for the supply of TWINRIX VACCINE, a combination hepatitis A and hepatitis B vaccine, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award, valued at $65,550.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine. The contract has an ultimate completion date of June 11, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $78,703.06 firm fixed-price delivery order is for the TWINRIX vaccine, a hepatitis A and hepatitis B combination vaccine, to be delivered by December 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the supply of the TWINRIX vaccine, a combination vaccine for Hepatitis A and Hepatitis B, to U.S. government agencies. The $3,447.90 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is the primary vehicle for Amerisourcebergen to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRTJ3
    Delivery Order

This federal contract award, valued at $2,312.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the TWINRIX vaccine, a hepatitis A and hepatitis B combination vaccine, and is a firm fixed-price delivery order with an ultimate completion date of August 29, 2024.

The contract is not designated with a set-aside requirement, indicating open competition. As a large, for-profit pharmaceutical company, AmerisourceBergen has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 10:43 AM